Search Results

1 - 10 of 12 items :

  • pharmacokinetics x
Clear All
In vitro antimicrobial activity of ethanolic extracts obtained from Ficus spp. leaves against the fish pathogen Aeromonas hydrophila

-736. Rigos G., Troisi G.M. 2005 - Antibacterial agents in Mediterranean finfish farming: A sinopsis of drug pharmacokinetics in important euryhaline fish species and possible environmental implications - Rev. Fish Biol. Fish. 15: 53-73. Rizvi W., Rizvi M., Kumar R., Kumar A., Shukla I., Parveen M. 2010 - Antibacterial activity of Ficus lyrata - An in vitro study - Int. J. Pharmacol. 8: 7. Sahu S., Das B.K., Pradhan J., Mohapatra B.C., Mishra B.K., Sarangi N. 2007 - Effect of Magnifera indica kernel as a feed additive on immunity and

Open access
Improving disease prevention and treatment in controlled fish culture

– Aquaculture 255: 179-187. Gould Ch. 2005 – Prophylaxis in trout culture – In: Schering–Plough Animal Health Training Materials, Puławy 15.10.2005 (in Polish). Grondel J.L., Gloudemans A.G.M., van Muiswinkel W.B. 1985 – The influence of antibiotics on the immune system. II. Modulation of fish leukocyte response in culture – Vet. Immunol. Immunopathol. 9: 251-260. Grondel J.L., Nouws J.F.M., Jong de Schutte A.R., Driessens F. 1987a – Pharmacokinetics and tissue distribution of oxytetracycline in carp, Cyprinus carpio L., following different routes of

Open access
Analysis of The Essential Oils of Thymus Kotschyanus L. (10 POPULATIONS) FROM IRAN

. European Journal of Drug Metabolism and Pharmacokinetics, 13th Pan-Hellenic Pharmaceutical Congress - Abstracts of Poster Presentations, 32, 31. Rechinger K.H., 1982 - Flora Iranica, vol. 152. Graz: Akademische Druck und Verlagsanstalt. Sefidkon F., Rahimi Bigdeli A., 1999 - Assess the quality/quantity of essential oils in thyme species ( Thymus kotschyanus ) with various distillation methods. Journal of Medicinal and Aromatic Plants in Iran 15:1-21. Sefidkon F., Kalvandi R., Atri M., Barazandeh M.M., 2005 - Essential oil variability of Thymus eriocalix

Open access
Endophytic fungi residing in medicinal plants have the ability to produce the same or similar pharmacologically active secondary metabolites as their hosts

baccata suspension cultures: A review. Process Biochemistry, 46: 23-34. Manda, V.K., Avula, B., Dale, O.R., Chittiboyina, A.G., Khan, I.A., Walker, L.A. and Khan, S.I. 2015. Studies on pharmacokinetic drug interaction potential of vinpocetine. Medicines, 2: 93-105. Ming, Q., Han, T., Li, W., Zhang, Q., Zhang, H., Zheng, C., and Qin, L. 2012. Tanshinone IIA and tanshinone I production by Trichoderma atroviride D16, an endophytic fungus in Salvia miltiorrhiza. Phytomedicine, 19: 330-333. Mir, R.A., Kaushik, S.P., Chowdery, R

Open access
The effects of flubendazole and its metabolites on the larval development of Haemonchus contortus (Nematoda: Trichostrongylidae): an in vitro study

pharmacokinetics. Acta Tropica, 86: 141–159 http://dx.doi.org/10.1016/S0001-706X(03)00031-7 [5] Dobson, R. J., Griffiths, D. A., Donald, A. D., Waller, P. J. (1987): A genetic model describing the evolution of levamisole resistance in Trichostrongylus colubriformis, a nematode parasite of sheep. IMA J. Appl. Math., 4: 279–293 http://dx.doi.org/10.1093/imammb/4.4.279 [6] Hubert, J., Kerboeuf, D. (1992): A microlarval development assay for the detection of anthelmintic resistance in sheep nematodes. Vet. Rec., 130: 442–446 http

Open access
Gastrointestinal helminth infections of dairy goats in Slovakia

nematodes in milking sheep and goats in Greece based on parasitological and performance criteria. Vet. Parasitol. , 164(1): 53 – 58. DOI:10.1016/j.vetpar.2009.04.011 G illham , R.J., O bendorf , D.L. (1985): Therapeutic failure of levamisole in dairy goats. Aust. Vet. J. , 62(12): 426 – 427. DOI: 10.1111/j.1751-0813.1985.tb14132.x G okbulut , C., Y alinkilinc , H.S., A ksit , D., V eneziano , V. (2014): Comparative pharmacokinetics of levamisole-oxyclozanide combination in sheep and goats following per os administration. Can. J. Vet. Res. , 78(4): 316

Open access
Clinical and serological study of human alveolar echinococcosis in Slovakia in relation to the outcome of chemotherapy

, M. C., Miguet, J. P. (2000): A 20-year history of alveolar echinococcosis in humans. Analysis of a series of 117 patients from eastern France. Eur. J. Gastroenterol. Hepatol., 12: 327–336 [4] Craig, P. (2003): Echinococcus multilocularis. Curr. Opin. Infect. Dis., 16: 437–444 http://dx.doi.org/10.1097/00001432-200310000-00010 [5] Dayan, A. D. (2003): Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica., 86: 141–159 http://dx.doi.org/10.1016/S0001-706X(03

Open access
Dehorning of Calves – Methods of Pain and Stress Alleviation – A Review

/12/1991. Council Directive 97/2/ECof 20 January 1997 amending Directive 91/629/EEClaying down minimum standards for the protection of calves. Official Journal L 025, 28/01/1997. Delatour P., Foot R., Foster A.P., Bagott D., Lees P. (1996). Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. Brit. Vet. J., 152: 183-198. Doherty T.J., Kattesh H.G., Adcock R.J., Welborn M.G., Saxton A.M., Morrow J.L., Dailey J.W. (2007). Effects ofaconcentrated lidocaine solution on the acute phase stress response to dehorning in dairy calves. J

Open access
The Effect of Administration of Silver Nanoparticles on the Immune Status of Chickens

extracellular nanoparticle clearance by human immune cells. Nano Lett., 10: 59-63. Bomski H. (1995). Biernacki’s reaction (in Polish). In: Basic hematology laboratory analyses, Bomski H. (ed.). National Institute of Medical Publications, Warsaw, pp. 161-168. Cho W.S., Cho M., Jeong J., Choi M., Cho H.Y., Han B.S., Kim S.H., Kim H.O., Lim Y.T., Chung B.H., Jeon J. (2009). Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Tox. Appl. Pharmacol., 236: 16-24. Chuammitri P., Ostojić J., Andreasen C

Open access
Immune response of mice to Echinococcus multilocularis infection after therapy with amphotericin B colloidal dispersion

. Vet. J., 165: 266–275 http://dx.doi.org/10.1016/S1090-0233(02)00158-2 [9] Christiansen, K. J., Bernard, E. M., Gold, J. W. M., Armstrong, D. (1985): Distribution and activity of amphotericin B in humans. J. Infect. Dis., 152: 1037–1043 [10] Clements, J. S. Jr., Peacock, J. E. Jr. (1990): Amphotericin B revisited: reassessment of toxicity. Amer. J. Med., 88: 22–27 [11] Clemons, K. V., Sobel, R. A., Williams, P. L., Stevens, D. A. (2001): Comparative toxicities and pharmacokinetics of

Open access